ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 676,87
-0,34%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Caladrius Biosciences Inc (CLBS)

  7. Caladrius Biosciences Inc (CLBS) Actualités

CLBS

Caladrius Biosciences (CLBS)

Caladrius Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CLBS
DateHeureSourceTitreSymboleSociété
09/05/202322h11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CLBSCaladrius Biosciences Inc
09/05/202322h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLBSCaladrius Biosciences Inc
30/03/202322h17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CLBSCaladrius Biosciences Inc
17/01/202323h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
17/10/202222h03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLBSCaladrius Biosciences Inc
14/10/202222h02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CLBSCaladrius Biosciences Inc
16/09/202222h52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLBSCaladrius Biosciences Inc
15/09/202215h15GlobeNewswire Inc.Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata TherapeuticsNASDAQ:CLBSCaladrius Biosciences Inc
14/09/202214h00GlobeNewswire Inc.Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata TherapeuticsNASDAQ:CLBSCaladrius Biosciences Inc
12/09/202214h35GlobeNewswire Inc.Life Sciences Virtual Investor Conference Agenda Announced for September 15thNASDAQ:CLBSCaladrius Biosciences Inc
08/09/202214h00GlobeNewswire Inc.Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022NASDAQ:CLBSCaladrius Biosciences Inc
15/08/202212h57Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLBSCaladrius Biosciences Inc
10/08/202217h40TipRanksAnalysts Conflicted on These Healthcare Names: Haemonetics (HAE), Caladrius Biosciences (CLBS) and Adicet Bio (ACET)NASDAQ:CLBSCaladrius Biosciences Inc
10/08/202214h00GlobeNewswire Inc.Caladrius Biosciences’ Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement with Roche to Evaluate CEND-1 in Combination with Immunotherapy to Treat Pancreatic CancerNASDAQ:CLBSCaladrius Biosciences Inc
07/08/202214h25TipRanksDawson James Sticks to Its Hold Rating for Caladrius Biosciences (CLBS)NASDAQ:CLBSCaladrius Biosciences Inc
05/08/202212h26TipRanksH.C. Wainwright Thinks Caladrius Biosciences’ Stock is Going to RecoverNASDAQ:CLBSCaladrius Biosciences Inc
04/08/202222h05GlobeNewswire Inc.Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:CLBSCaladrius Biosciences Inc
02/08/202214h00GlobeNewswire Inc.Caladrius Biosciences Completes Enrollment in Phase 1b Study of CLBS201 for the Treatment of Diabetic Kidney DiseaseNASDAQ:CLBSCaladrius Biosciences Inc
29/07/202222h07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CLBSCaladrius Biosciences Inc
28/07/202214h00GlobeNewswire Inc.Caladrius Biosciences to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022, at 4:30 p.m. Eastern TimeNASDAQ:CLBSCaladrius Biosciences Inc
06/07/202214h00GlobeNewswire Inc.Caladrius Biosciences and Cend Therapeutics Announce Publication of Pancreatic Cancer Trial Data in The Lancet Gastroenterology and HepatologyNASDAQ:CLBSCaladrius Biosciences Inc
09/06/202214h00GlobeNewswire Inc.Caladrius Biosciences Announces Merger Partner, Cend Therapeutics, has Treated First Patient in Phase 2b Trial of CEND-1 in Collaboration with Australasian Gastro-Intestinal Cancer Trials GroupNASDAQ:CLBSCaladrius Biosciences Inc
08/06/202214h00GlobeNewswire Inc.Caladrius Biosciences to Present at the BIO International Convention 2022NASDAQ:CLBSCaladrius Biosciences Inc
26/05/202214h00GlobeNewswire Inc.Caladrius Biosciences and Cend Therapeutics Announce Poster Presentation at the 2022 American Society of Clinical Oncology Annual MeetingNASDAQ:CLBSCaladrius Biosciences Inc
24/05/202216h15TipRanksCaladrius Biosciences (CLBS) Gets a Buy Rating from Brookline Capital MarketsNASDAQ:CLBSCaladrius Biosciences Inc
24/05/202215h15TipRanksAnalysts Offer Insights on Healthcare Companies: Caladrius Biosciences (CLBS) and Alzamend Neuro (ALZN)NASDAQ:CLBSCaladrius Biosciences Inc
23/05/202222h05GlobeNewswire Inc.Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular DysfunctionNASDAQ:CLBSCaladrius Biosciences Inc
19/05/202214h00GlobeNewswire Inc.Caladrius Biosciences Announces IDMC Recommendation to Advance CLBS201 Trial for the Treatment of Diabetic Kidney DiseaseNASDAQ:CLBSCaladrius Biosciences Inc
18/05/202214h00GlobeNewswire Inc.Caladrius Biosciences to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:CLBSCaladrius Biosciences Inc
09/05/202208h16TipRanksBrookline Capital Markets Thinks Caladrius Biosciences’ Stock is Going to RecoverNASDAQ:CLBSCaladrius Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CLBS

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
EU
BN
Danone
NYSE
JPM
JP Morgan Chase
EU
BNP
BNP Paribas
EU
ML
Michelin
COIN
BTCUSD
Bitcoin
EU
AI
Air Liquide
NASDAQ
GOOGL
Alphabet
EU
SGO
Cie de SaintGobain
NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés